Dear colleagues
I am writing to you as you have previously attended or expressed an interest in our NU Innovates Seminar Series, http://www.newcastleptd.com/nu-innovates/ . I would also like to remind you that the Newcastle MRC Proximity to Discovery Reactive scheme is always open, http://www.newcastleptd.com/apply/ !
The fifth NU Innovates Seminar takes place next week, and offers an opportunity to learn about opportunities to collaborate with GSK.
NU Innovates: Collaborate with GSK
Guest Speaker: Iain Uings, Director of Discovery Partnerships with Academia at GlaxoSmithKline
Date/Time: Monday 30th July 2018, 11:00 – 12.00
Venue: Dental Lecture Theatre E, Medical School
Iain Uings, will provide details of the GSK Discovery Partnership for Academia scheme (http://www.dpac.gsk.com/). This scheme is designed to provide industrial drug discovery resources and expertise to academic researchers. GSK is interested in any disease area and based on any treatment modality, be it small molecule or biopharmaceutical. GSK will undertake projects starting from early screening to late lead optimisation.
A DPAc partnership offers you:
- A single partner to develop an idea into a therapeutic
- Collaboration with GSK researchers with the skills and resources to meet your needs
- Access to state-of-the-art drug discovery platforms
- A financial share in the success of any future medicines
To register for this event please email me, Sarah.Greenhalgh@newcastle.ac.uk.
The NU Innovates program is supported by the University’s MRC Proximity to Discovery scheme.